All News Biosynex

Equities

ALBIO

FR0011005933

Market Closed - Euronext Paris Other stock markets 10:31:49 2024-05-17 am EDT			5-day change	1st Jan Change
4.04 ^EUR	-0.37%		-1.46%	-51.62%

May. 13	Biosynex: Oren Bitton appointed Chief Operating Officer	CF
Apr. 30	Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biosynex: Oren Bitton appointed Chief Operating Officer	May. 13	CF
Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30	CI
Biosynex: agreement for ProciseDx in North America	Apr. 29	CF
Biosynex: merger with Theradiag completed	Dec. 18	CF
Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-29	CI
Biosynex: acquisition of Qualigen in the United States	23-07-21	CF
Biosynex Unit to Acquire US-based Biotech Qualigen	23-07-21	MT
Biosynex SA acquired 57.33% interest in ProciseDx Inc. from Nestlé HealthCare Nutrition, Inc., other shareholders, employees, former employees and investors.	23-06-12	CI
Biosynex SA signed an agreement to acquire 57.33% interest in ProciseDx Inc. from NestlÃ© HealthCare Nutrition, Inc., other shareholders, employees, former employees and investors.	23-06-11	CI
Biosynex: acquires Innoxa's eye care business	23-06-08	CF
Biosynex SA acquired Eye Care activity from LABORATOIRES INNOXA.	23-06-07	CI
Biosynex Completes Acquisition of Chembio Diagnostics, Inc.	23-04-27	AQ
Biosynex SA completed the acquisition of Chembio Diagnostics, Inc. from Perceptive Advisors LLC and others.	23-04-26	CI
Global markets live: EssilorLuxottica, AT&T, Tesla, Credit Suisse, Sony...	23-04-21
Biosynex: share price falls as results deteriorate	23-04-21	CF
Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-20	CI
Chembio Diagnostics Tender Offer Expiration Extended by Biosynex	23-04-13	MT
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.	23-04-13	AQ
Biosynex: takeover bid extended for Chembio Diagnostics	23-03-29	CF
Biosynex Unit Extends Expiration Time of Tender Offer for Chembio Diagnostics Shares; Stock Rises	23-03-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Biosynex

Equities

ALBIO

FR0011005933

All News

Filters